Proliferation and signaling in fibroblasts -: Role of 5-hydroxytryptamine2A receptor and transporter

被引:83
作者
Welsh, DJ
Harnett, M
Maclean, M
Peacock, AJ
机构
[1] Western Infirm & Associated Hosp, Scottish Pulm Vasc Unit, Glasgow G11 6NT, Lanark, Scotland
[2] Western Infirm & Associated Hosp, Dept Immunol, Glasgow G11 6NT, Lanark, Scotland
[3] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland
关键词
fibroblasts; hypoxia; pulmonary; pulmonary hypertension; 5-hydroxytryptamine;
D O I
10.1164/rccm.200302-264OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
5-Hydroxytryptamine (5-HT) plays an important role in the remodeling of the pulmonary circulation, notably during exposure to hypoxia. Here, we have been interested in the role of 5-HT and the 5-HT transporter in the proliferation of pulmonary artery fibroblasts derived from pulmonary hypertensive animals and particularly in defining which receptor subtype is of importance and in identifying a possible mechanism of this effect. This study has examined the effects of 5-HT on the proliferation and activation of mitogen-activated protein kinases in rat pulmonary artery fibroblasts from control and chronically hypoxic animals. We have shown that 5-HT has a co-mitogenic effect with serum to produce an enhanced proliferative response in cells from chronically hypoxic rats over those from control animals. Moreover we have found that the 5-HT2A receptor is responsible for the hypoxia-associated 5-HT proliferation in these cells by using specific receptor agonist and antagonist studies and that this receptor signals via p38 mitogen-activated protein kinase. We have also shown that the 5-HT transporter is important in the mitogenic response not pertaining to hypoxic stimulation. Taken together, these data suggest that selective 5-HT2A receptor antagonists may have a role in pulmonary artery fibroblast proliferation to hypoxia.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 30 条
[1]  
BITTERMAN PB, 1991, CHEST, V99, P185
[2]   REFLEX AND DIRECT CARDIOPULMONARY EFFECTS OF 5-OH-TRYPTAMINE (SEROTONIN) - THEIR POSSIBLE ROLE IN PULMONARY EMBOLISM AND CORONARY THROMBOSIS [J].
COMROE, JH ;
VANLINGEN, B ;
STROUD, RC ;
RONCORONI, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1953, 173 (03) :379-386
[3]   Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene [J].
Eddahibi, S ;
Hanoun, N ;
Lanfumey, L ;
Lesch, KP ;
Raffestin, B ;
Hamon, M ;
Adnot, S .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1555-1562
[4]   Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease [J].
Eddahibi, S ;
Chaouat, A ;
Morrell, N ;
Fadel, E ;
Fuhrman, C ;
Bugnet, AS ;
Dartevelle, P ;
Housset, B ;
Hamon, M ;
Weitzenblum, E ;
Adnot, S .
CIRCULATION, 2003, 108 (15) :1839-1844
[5]  
Florian JA, 1998, J PHARMACOL EXP THER, V284, P346
[6]  
FRESHNEY RI, 1983, CULTURE ANIMAL CELLS, P99
[7]   SEROTONIN AND SEROTONIN ANTAGONISM IN CARDIOVASCULAR AND NON-CARDIOVASCULAR DISEASE [J].
FRISHMAN, WH ;
HUBERFELD, S ;
OKIN, S ;
WANG, YH ;
KUMAR, A ;
SHAREEF, B .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (06) :541-572
[8]  
GOSNEY J, 1989, ARCH PATHOL LAB MED, V113, P337
[9]  
HEFFNER JE, 1987, AM REV RESPIR DIS, V135, P482
[10]  
HOYER D, 1994, PHARMACOL REV, V46, P157